Can a conversation between mesenchymal stromal cells and macrophages solve the crisis in the inflamed intestine?

Frontiers in Pharmacology

Volumn 9, Issue MAR, 2018, Pages

  Hidalgo Garcia, Laura ^a   Galvez, Julio ^a   Rodriguez Cabezas, M Elena ^a   Anderson, Per O ^a  

^a UNIVERSITY OF GRANADA   (Spain)

Author keywords

IL 10; Inflammatory bowel disease; M1 M2 macrophage polarization; Mesenchymal stem cells; Multipotent mesenchymal stromal cells; PGE2

Indexed keywords

5' NUCLEOTIDASE; ARGINASE 1; CD11B ANTIGEN; CD14 ANTIGEN; CD19 ANTIGEN; CD34 ANTIGEN; CD79A ANTIGEN; CHEMOKINE RECEPTOR CCR2; COLONY STIMULATING FACTOR 1; ENDOGLIN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEME OXYGENASE 1; HLA DR ANTIGEN; INDOLEAMINE 2,3 DIOXYGENASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 23; INTERLEUKIN 4; INTERLEUKIN 6; MANNOSE RECEPTOR; RECEPTOR TYPE TYROSINE PROTEIN PHOSPHATASE C; SCATTER FACTOR; THY 1 MEMBRANE GLYCOPROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; UNINDEXED DRUG;

CELL DIFFERENTIATION; CELL PLASTICITY; CELL POLARITY; CELL POPULATION; CELL VIABILITY; CROHN DISEASE; DISEASE SEVERITY; HEMATOPOIESIS; HUMAN; IMMUNOMODULATION; IN VITRO STUDY; INTESTINE FLORA; MACROPHAGE; MACROPHAGE ACTIVATION; MESENCHYMAL STROMA CELL; NONHUMAN; PATHOGENESIS; PHENOTYPE; PROTEIN EXPRESSION; QUALITY OF LIFE; RELAPSE; REMISSION; REVIEW; ULCERATIVE COLITIS; UPREGULATION;

EID: 85043331469     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2018.00179     Document Type: Review

References (127)

1. Anderson, P., Carrillo-Gálvez, A. B., García-Pérez, A., Cobo, M., Martín, F., and Menendez, P. (2013a). CD105 (Endoglin)-negative murine mesenchymal stromal cells define a new multipotent subpopulation with distinct differentiation and immunomodulatory capacities. PLoS ONE 8:e76979. doi: 10.1371/journal.pone.0076979
2. Anderson, P., Gonzalez-Rey, E., O'valle, F., Martin, F., Oliver, F. J., and Delgado, M. (2017). Allogeneic adipose-derived mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by regulating self-reactive T cell responses and dendritic cell function. Stem Cells Int. 2017:2389753. doi: 10.1155/2017/2389753
3. Anderson, P., Souza-Moreira, L., Morell, M., Caro, M., O'valle, F., Gonzalez-Rey, E., et al. (2013b). Adipose-derived mesenchymal stromal cells induce immunomodulatory macrophages which protect from experimental colitis and sepsis. Gut 62, 1131-1141. doi: 10.1136/gutjnl-2012-302152
4. Ankrum, J. A., Ong, J. F., and Karp, J. M. (2014). Mesenchymal stem cells: immune evasive, not immune privileged. Nat. Biotechnol. 32, 252-260. doi: 10.1038/nbt.2816
5. Bain, C. C., and Mowat, A. M. (2014). Macrophages in intestinal homeostasis and inflammation. Immunol. Rev. 260, 102-117. doi: 10.1111/imr.12192
6. Bain, C. C., Bravo-Blas, A., Scott, C. L., Gomez Perdiguero, E., Geissmann, F., Henri, S., et al. (2014). Constant replenishment from circulating monocytes maintains the macrophage pool in the intestine of adult mice. Nat. Immunol. 15, 929-937. doi: 10.1038/ni.2967
7. Bazhanov, N., Ylostalo, J. H., Bartosh, T. J., Tiblow, A., Mohammadipoor, A., Foskett, A., et al. (2016). Intraperitoneally infused human mesenchymal stem cells form aggregates with mouse immune cells and attach to peritoneal organs. Stem Cell Res. Ther. 7:27. doi: 10.1186/s13287-016-0284-5
8. Bernstein, C. N. (2015). Treatment of IBD: where we are and where we are going. Am. J. Gastroenterol. 110, 114-126. doi: 10.1038/ajg.2014.357
9. Bianco, P., Cao, X., Frenette, P. S., Mao, J. J., Robey, P. G., Simmons, P. J., et al. (2013). The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine. Nat. Med. 19, 35-42. doi: 10.1038/nm.3028
10. Bianco, P., Robey, P. G., and Simmons, P. J. (2008). Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell. 2, 313-319. doi: 10.1016/j.stem.2008.03.002
11. Braza, F., Dirou, S., Forest, V., Sauzeau, V., Hassoun, D., Chesné, J., et al. (2016). Mesenchymal stem cells induce suppressive macrophages through phagocytosis in a mouse model of asthma. Stem Cells 34, 1836-1845. doi: 10.1002/stem.2344
12. Carty, F., Mahon, B. P., and English, K. (2017). The influence of macrophages on mesenchymal stromal cell therapy: passive or aggressive agents? Clin. Exp. Immunol. 188, 1-11. doi: 10.1111/cei.12929
13. Castelo-Branco, M. T., Soares, I. D., Lopes, D. V., Buongusto, F., Martinusso, C. A., do Rosario, A. Jr., et al. (2012). Intraperitoneal but not intravenous cryopreserved mesenchymal stromal cells home to the inflamed colon and ameliorate experimental colitis. PLoS ONE 7:e33360. doi: 10.1371/journal.pone.0033360
14. Chamberlain, G., Wright, K., Rot, A., Ashton, B., and Middleton, J. (2008). Murine mesenchymal stem cells exhibit a restricted repertoire of functional chemokine receptors: comparison with human. PLoS ONE 3:e2934. doi: 10.1371/journal.pone.0002934
15. Chen, K., Liu, Q., Tsang, L. L., Ye, Q., Chan, H. C., Sun, Y., et al. (2017). Human MSCs promotes colorectal cancer epithelial-mesenchymal transition and progression via CCL5/β-catenin/Slug pathway. Cell Death Dis. 8:e2819. doi: 10.1038/cddis.2017.138
16. Chinnadurai, R., Copland, I. B., Ng, S., Garcia, M., Prasad, M., Arafat, D., et al. (2015). Mesenchymal stromal cells derived from Crohn's patients deploy indoleamine 2, 3-dioxygenase-mediated immune suppression, independent of autophagy. Mol. Ther. 23, 1248-1261. doi: 10.1038/mt.2015.67
17. Chiossone, L., Conte, R., Spaggiari, G. M., Serra, M., Romei, C., Bellora, F., et al. (2016). Mesenchymal stromal cells induce peculiar alternatively activated macrophages capable of dampening both innate and adaptive immune responses. Stem Cells 34, 1909-1921. doi: 10.1002/stem.2369
18. Cho, D.-I., Kim, M. R., Jeong, H.-Y., Chang Jeong, H., Jeong, M. H., Yoon, S. H., et al. (2014). Mesenchymal stem cells reciprocally regulate the M1/M2 balance in mouse bone marrow-derived macrophages. Exp. Mol. Med. 46:e70. doi: 10.1038/emm.2013.135
19. Ciccocioppo, R., Bernardo, M. E., Sgarella, A., Maccario, R., Avanzini, M. A., Ubezio, C., et al. (2011). Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease. Gut 60, 788-798. doi: 10.1136/gut.2010.214841
20. Ciccocioppo, R., Gallia, A., Sgarella, A., Kruzliak, P., Gobbi, P. G., and Corazza, G. R. (2015). Long-term follow-up of Crohn disease fistulas after local injections of bone marrow-derived mesenchymal stem cells. Mayo Clin. Proc. 90, 747-755. doi: 10.1016/j.mayocp.2015.03.023
21. Coccia, M., Harrison, O. J., Schiering, C., Asquith, M. J., Becher, B., Powrie, F., et al. (2012). IL-1β mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4 + Th17 cells. J. Exp. Med. 209, 1595-1609. doi: 10.1084/jem.20111453
22. Connick, P., Kolappan, M., Crawley, C., Webber, D. J., Patani, R., Michell, A. W., et al. (2012). Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study. Lancet Neurol. 11, 150-156. doi: 10.1016/S1474-4422(11)70305-2
23. Constantin, G., Marconi, S., Rossi, B., Angiari, S., Calderan, L., Anghileri, E., et al. (2009). Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis. Stem Cells 27, 2624-2635. doi: 10.1002/stem.194
24. da Silva Meirelles, L. (2006). Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J. Cell Sci. 119, 2204-2213. doi: 10.1242/jcs.02932
25. Danese, S., Vuitton, L., and Peyrin-Biroulet, L. (2015). Biologic agents for IBD: practical insights. Nat. Rev. Gastroenterol. Hepatol. 12, 537-545. doi: 10.1038/nrgastro.2015.135
26. Dave, M., Jaiswal, P., and Cominelli, F. (2017). Mesenchymal stem/stromal cell therapy for inflammatory bowel disease: an updated review with maintenance of remission. Curr. Opin. Gastroenterol. 33, 59-68. doi: 10.1097/MOG.0000000000000327
27. Davis, M. J., Tsang, T. M., Qiu, Y., Dayrit, J. K., Freij, J. B., Huffnagle, G. B., et al. (2013). Macrophage M1/M2 polarization dynamically adapts to changes in cytokine microenvironments in Cryptococcus neoformans infection. MBio 4:e00264-13. doi: 10.1128/mBio.00264-13
28. de Aguiar, C. F., Castoldi, A., Andrade-Oliveira, V., Ignacio, A., da Cunha, F. F., Felizardo, R. J. F., et al. (2018). Mesenchymal stromal cells modulate gut inflammation in experimental colitis. Inflammopharmacology 26, 251-260. doi: 10.1007/s10787-017-0404-6
29. De Becker, A., and Van Riet, I. (2016). Homing and migration of mesenchymal stromal cells: how to improve the efficacy of cell therapy? World J. Stem Cells 8:73. doi: 10.4252/wjsc.v8.i3.73
30. de Souza, H. S. P., Fiocchi, C., and Iliopoulos, D. (2017). The IBD interactome: an integrated view of aetiology, pathogenesis and therapy. Nat. Rev. Gastroenterol. Hepatol. 14, 739-749. doi: 10.1038/nrgastro.2017.110
31. Deng, Y., Zhang, Y., Ye, L., Zhang, T., Cheng, J., Chen, G., et al. (2016). Umbilical cord-derived mesenchymal stem cells instruct monocytes towards an IL10-producing phenotype by secreting IL6 and HGF materials and methods. Sci. Rep. 6:37566. doi: 10.1038/srep37566
32. Di Nicola, M., Carlo-Stella, C., Magni, M., Milanesi, M., Longoni, P. D., Matteucci, P., et al. (2002). Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99, 3338-3343. doi: 10.1182/blood.V99.10.3838
33. Dietz, A. B., Dozois, E. J., Fletcher, J. G., Butler, G. W., Radel, D., Lightner, A. L., et al. (2017). Autologous mesenchymal stem cells, applied in a bioabsorbable matrix, for treatment of perianal fistulas in patients with Crohn's disease. Gastroenterology 153, 59.e2-62.e2. doi: 10.1053/j.gastro.2017.04.001
34. Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., et al. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy 8, 315-317. doi: 10.1080/14653240600855905
35. Du Plessis, J., Vanheel, H., Janssen, C. E. I., Roos, L., Slavik, T., Stivaktas, P. I., et al. (2013). Activated intestinal macrophages in patients with cirrhosis release NO and IL-6 that may disrupt intestinal barrier function. J. Hepatol. 58, 1125-1132. doi: 10.1016/j.jhep.2013.01.038
36. Duijvestein, M., Christine Vos, A. W., Roelofs, H., Wildenberg, M. E., Wendrich, B. B., Verspaget, H. W., et al. (2010). Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study. Gut 59, 1662-1669. doi: 10.1136/gut.2010.215152
37. Duijvestein, M., Molendijk, I., Roelofs, H., Vos, A. C., Verhaar, A. P., Reinders, M. E., et al. (2011a). Mesenchymal stromal cell function is not affected by drugs used in the treatment of inflammatory bowel disease. Cytotherapy 13, 1066-1073. doi: 10.3109/14653249.2011.597379
38. Duijvestein, M., Wildenberg, M. E., Welling, M. M., Hennink, S., Molendijk, I., van Zuylen, V. L., et al. (2011b). Pretreatment with interferon-α enhances the therapeutic activity of mesenchymal stromal cells in animal models of colitis. Stem Cells 29, 1549-1558. doi: 10.1002/stem.698
39. Fan, H., Zhao, G., Liu, L., Liu, F., Gong, W., Liu, X., et al. (2012). Pre-treatment with IL-1β enhances the efficacy of MSC transplantation in DSS-induced colitis. Cell. Mol. Immunol. 940, 473-481. doi: 10.1038/cmi.2012.40
40. Forbes, G. M., Sturm, M. J., Leong, R. W., Sparrow, M. P., Segarajasingam, D., Cummins, A. G., et al. (2014). A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn's disease refractory to biologic therapy. Clin. Gastroenterol. Hepatol. 12, 64-71. doi: 10.1016/j.cgh.2013.06.021
41. François, M., Romieu-Mourez, R., Li, M., and Galipeau, J. (2012). Human MSC suppression correlates with cytokine induction of indoleamine 2, 3-dioxygenase and bystander M2 macrophage differentiation. Mol. Ther. 20, 187-195. doi: 10.1038/mt.2011.189
42. Friedenstein, A. J. (1990). 'Osteogenic stem cells in bone marrow, ' in Bone and Mineral Research, eds J. N. M. Heersche and J. A. Kanis (Netherlands: Elsevier Science Publishers), 243-272
43. Gao, F., Chiu, S., Motan, D., Zhang, Z., Chen, L., Ji, H.-L., et al. (2016). Mesenchymal stem cells and immunomodulation: current status and future prospects. Cell Death Dis. 7:e2062. doi: 10.1038/cddis.2015.327
44. Garg, S. K., Croft, A. M., and Bager, P. (2014). 'Helminth therapy (worms) for induction of remission in inflammatory bowel disease, ' in Cochrane Database of Systematic Reviews, ed S. K. Garg (Chichester: John Wiley & Sons, Ltd)
45. Glocker, E.-O., Kotlarz, D., Boztug, K., Michael Gertz, E., Schäffer, A. A., Noyan, F., et al. (2009). Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N. Engl. J. Med. 361, 2033-2045. doi: 10.1056/NEJMoa0907206
46. Gonzalez-Rey, E., Anderson, P., González, M. A., Rico, L., Büscher, D., and Delgado, M. (2009). Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis. Gut 58l, 929-939. doi: 10.1136/gut.2008.168534
47. Grimm, M. C., Pavli, P., Van De Pol, E., and Doe, W. F. (1995). Evidence for a CD14+ population of monocytes in inflammatory bowel disease mucosa-implications for pathogenesis. Clin. Exp. Immunol. 100, 291-297. doi: 10.1111/j.1365-2249.1995.tb03667.x
48. Hayashi, Y., Tsuji, S., Tsujii, M., Nishida, T., Ishii, S., Iijima, H., et al. (2008). Topical implantation of mesenchymal stem cells has beneficial effects on healing of experimental colitis in rats. J. Pharmacol. Exp. Ther. 326, 523-531. doi: 10.1124/jpet.108.137083
49. Henao Agudelo, J. S., Braga, T. T., Amano, M. T., Cenedeze, M. A., Cavinato, R. A., Peixoto-Santos, A. R., et al. (2017). Mesenchymal stromal cell-derived microvesicles regulate an internal pro-inflammatory program in activated macrophages. Front. Immunol. 8:881. doi: 10.3389/fimmu.2017.00881
50. Hill Charles, D., Mills, A. M., Kincaid, K., Alt, J. M., Mills, C. D., Heilman, M. J., et al. (2000). Paradigm M-1/M-2 Macrophages and the Th1/Th2 M-1/M-2 macrophages and the Th1/Th2 paradigm. J. Immunol. 164, 6166-6173. doi: 10.4049/jimmunol.164.12.6166
51. Honczarenko, M., Le, Y., Swierkowski, M., Ghiran, I., Glodek, A. M., and Silberstein, L. E. (2006). Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells 24, 1030-1041. doi: 10.1634/stemcells.2005-0319
52. Hu, J., Zhao, G., Zhang, L., Qiao, C., Di, A., Gao, H., et al. (2016). Safety and therapeutic effect of mesenchymal stem cell infusion on moderate to severe ulcerative colitis. Exp. Ther. Med. 12, 2983-2989. doi: 10.3892/etm.2016.3724
53. Hunter, M. M., Wang, A., Parhar, K. S., Johnston, M. J. G., Van Rooijen, N., Beck, P. L., et al. (2010). In vitro-derived alternatively activated macrophages reduce colonic inflammation in mice. Gastroenterology 138, 1395-1405. doi: 10.1053/j.gastro.2009.12.041
54. Isidro, R. A., and Appleyard, C. B. (2016). Colonic macrophage polarization in homeostasis, inflammation, and cancer. Am. J. Physiol. Gastrointest. Liver Physiol. 311, G59-G73. doi: 10.1152/ajpgi.00123.2016
55. Italiani, P., and Boraschi, D. (2014). From Monocytes to M1/M2 Macrophages: phenotypical vs. functional differentiation. Front. Immunol. 5:514. doi: 10.3389/fimmu.2014.00514
56. Joeris, T., Müller-Luda, K., Agace, W., and Mowat, A. M. (2017). Diversity and functions of intestinal mononuclear phagocytes. Mucosal Immunol. 10, 845-864. doi: 10.1038/mi.2017.22
57. Kidd, S., Spaeth, E., Dembinski, J. L., Dietrich, M., Watson, K., Klopp, A., et al. (2009). Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescence imaging. Stem Cells 27, 2614-2623. doi: 10.1002/stem.187
58. Kudlik, G., Hegyi, B., Czibula, á., Monostori, é., Buday, L., and Uher, F. (2016). Mesenchymal stem cells promote macrophage polarization toward M2b-like cells. Exp. Cell Res. 348, 36-45. doi: 10.1016/j.yexcr.2016.08.022
59. Lee, S. H., Starkey, P. M., and Gordon, S. (1985). Quantitative analysis of total macrophage content in adult mouse tissues. Immunochemical studies with monoclonal antibody F4/80. J. Exp. Med. 161, 475-489. doi: 10.1084/jem.161.3.475
60. Leung, G., Wang, A., Fernando, M., Phan, V. C., and McKay, D. M. (2013). Bone marrow-derived alternatively activated macrophages reduce colitis without promoting fibrosis: participation of IL-10. Am. J. Physiol. Gastrointest. Liver Physiol. 304, G781-G792. doi: 10.1152/ajpgi.00055.2013
61. Li, L., Liu, S., Xu, Y., Zhang, A., Jiang, J., Tan, W., et al. (2013). Human umbilical cord-derived mesenchymal stem cells downregulate inflammatory responses by shifting the Treg/Th17 profile in experimental colitis. Pharmacology 92, 257-264. doi: 10.1159/000354883
62. Li, Q., Wang, D., Hao, S., Han, X., Xia, Y., Li, X., et al. (2017). CD169 expressing macrophage, a key subset in mesenteric lymph nodes promotes mucosal inflammation in dextran sulfate sodium-induced colitis. Front. Immunol. 8:669. doi: 10.3389/fimmu.2017.00669
63. Liang, L., Dong, C., Chen, X., Fang, Z., Xu, J., Liu, M., et al. (2011). Human umbilical cord mesenchymal stem cells ameliorate mice trinitrobenzene sulfonic acid (TNBS)-induced colitis. Cell Transplant. 20, 1395-1408. doi: 10.3727/096368910X557245
64. Liu, W., Zhang, S., Gu, S., Sang, L., and Dai, C. (2015). Mesenchymal stem cells recruit macrophages to alleviate experimental colitis through TGFβ1. Cell. Physiol. Biochem. 35, 858-865. doi: 10.1159/000369743
65. Lo Sicco, C., Reverberi, D., Balbi, C., Ulivi, V., Principi, E., Pascucci, L., et al. (2017). Mesenchymal stem cell-derived extracellular vesicles as mediators of anti-inflammatory effects: endorsement of macrophage polarization. Stem Cells Transl. Med. 6, 1018-1028. doi: 10.1002/sctm.16-0363
66. Luk, F., de Witte, S. F., Korevaar, S. S., Roemeling-van Rhijn, M., Franquesa, M., Strini, T., et al. (2016). Inactivated mesenchymal stem cells maintain immunomodulatory capacity. Stem Cells Dev. 25, 1342-1354. doi: 10.1089/scd.2016.0068
67. Magatti, M., Vertua, E., De Munari, S., Caro, M., Caruso, M., Silini, A., et al. (2017). Human amnion favours tissue repair by inducing the M1-to-M2 switch and enhancing M2 macrophage features. J. Tissue Eng. Regen. 11, 2895-2911. doi: 10.1002/term.2193
68. Maggini, J., Mirkin, G., Bognanni, I., Holmberg, J., Piazzón, I. M., Nepomnaschy, I., et al. (2010). Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile. PLoS ONE 5:e9252. doi: 10.1371/journal.pone.0009252
69. Maheshwari, A., Kelly, D. R., Nicola, T., Ambalavanan, N., Jain, S. K., Murphy-Ullrich, J., et al. (2011). TGF-β 2 suppresses macrophage cytokine production and mucosal inflammatory responses in the developing intestine. Gastroenterology 140, 242-253. doi: 10.1053/j.gastro.2010.09.043
70. Manferdini, C., Paolella, F., Gabusi, E., Gambari, L., Piacentini, A., Filardo, G., et al. (2017). Adipose stromal cells mediated switching of the pro-inflammatory profile of M1-like macrophages is facilitated by PGE2: in vitro evaluation. Osteoarthr. Cartil. 25, 1161-1171. doi: 10.1016/j.joca.2017.01.011
71. Mantovani, A., Sica, A., Sozzani, S., Allavena, P., Vecchi, A., and Locati, M. (2004). The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25, 677-686. doi: 10.1016/j.it.2004.09.015
72. Mao, F., Wu, Y., Tang, X., Kang, J., Zhang, B., Yan, Y., et al. (2017a). Exosomes derived from human umbilical cord mesenchymal stem cells relieve inflammatory bowel disease in mice. Biomed Res. Int. 2017:5356760. doi: 10.1155/2017/5356760
73. Mao, F., Wu, Y., Tang, X., Wang, J., Pan, Z., Zhang, P., et al. (2017b). Human umbilical cord mesenchymal stem cells alleviate inflammatory bowel disease through the regulation of 15-LOX-1 in macrophages. Biotechnol. Lett. 39, 929-938. doi: 10.1007/s10529-017-2315-4
74. Markovic, B. S., Nikolic, A., Gazdic, M., Nurkovic, J., Djordjevic, I., Arsenijevic, N., et al. (2015). Pharmacological inhibition of Gal-3 in mesenchymal stem cells enhances their capacity to promote alternative activation of macrophages in dextran sulphate sodium-induced colitis. Stem Cells Int. 2016:2640746. doi: 10.1155/2016/2640746
75. Martinez, F. O., and Gordon, S. (2014). The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep. 6:13. doi: 10.12703/P6-13
76. Melief, S. M., Geutskens, S. B., Fibbe, W. E., and Roelofs, H. (2013a). Multipotent stromal cells skew monocytes towards an anti-inflammatory interleukin-10-producing phenotype by production of interleukin-6. Haematologica 98, 888-895. doi: 10.3324/haematol.2012.078055
77. Melief, S. M., Schrama, E., Brugman, M. H., Tiemessen, M. M., Hoogduijn, M. J., Fibbe, W. E., et al. (2013a). Multipotent stromal cells induce human regulatory T cells through a novel pathway involving skewing of monocytes toward anti-inflammatory macrophages. Stem Cells 31, 1980-1991. doi: 10.1002/stem.1432
78. Méndez-Ferrer, S., Michurina, T. V., Ferraro, F., Mazloom, A. R., Macarthur, B. D., Lira, S. A., et al. (2010). Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466, 829-834. doi: 10.1038/nature09262
79. Molendijk, I., Bonsing, B. A., Roelofs, H., Peeters, K. C., Wasser, M. N., Dijkstra, G., et al. (2015). Allogeneic bone marrow-derived mesenchymal stromal cells promote healing of refractory perianal fistulas in patients with Crohn's disease. Gastroenterology 149, 918.e6-927.e6. doi: 10.1053/j.gastro.2015.06.014
80. Murray, P. J. (2017). Macrophage polarization. Annu. Rev. Physiol. 79, 541-566. doi: 10.1146/annurev-physiol-022516-034339
81. Murray, P. J., Allen, J. E., Biswas, S. K., Fisher, E. A., Gilroy, D. W., Goerdt, S., et al. (2014). Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 41, 14-20. doi: 10.1016/j.immuni.2014.06.008
82. Nakajima, H., Uchida, K., Rodriguez Guerrero, A., Watanabe, S., Sugita, D., Takeura, N., et al. (2012). Transplantation of mesenchymal stem cells promotes an alternative pathway of macrophage activation and functional recovery after spinal cord injury. J. Neurotrauma 29, 1614-1625. doi: 10.1089/neu.2011.2109
83. Németh, K., Leelahavanichkul, A., Yuen, P. S. T., Mayer, B., Parmelee, A., Doi, K., et al. (2009). Bone marrow stromal cells attenuate sepsis via prostaglandin E2-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat. Med. 15, 42-49. doi: 10.1038/nm.1905
84. Onishi, R., Ohnishi, S., Higashi, R., Watari, M., Yamahara, K., Okubo, N., et al. (2015). Human amnion-derived mesenchymal stem cell transplantation ameliorates dextran sulfate sodium-induced severe colitis in rats. Cell Transplant. 24, 2601-2614. doi: 10.3727/096368915X687570
85. Owen, M., and Friedenstein, A. J. (1988). Stromal stem cells: marrow-derived osteogenic precursors. Ciba Found. Symp. 136, 42-60
86. Panés, J., García-Olmo, D., Van Assche, G., Colombel, J. F., Reinisch, W., Baumgart, D. C., et al. (2016). Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial. Lancet 388, 1281-1290. doi: 10.1016/S0140-6736(16)31203-X
87. Parekkadan, B., Upadhyay, R., Dunham, J., Iwamoto, Y., Mizoguchi, E., Mizoguchi, A., et al. (2011). Bone marrow stromal cell transplants prevent experimental enterocolitis and require host CD11b+ Splenocytes. Gastroenterology 140, 966-975. doi: 10.1053/j.gastro.2010.10.013
88. Phinney, D. G., Di Giuseppe, M., Njah, J., Sala, E., Shiva, S., St Croix, C. M., et al. (2015). Mesenchymal stem cells use extracellular vesicles to outsource mitophagy and shuttle microRNAs. Nat. Commun. 6:8472. doi: 10.1038/ncomms9472
89. Popov, A., Driesen, J., Abdullah, Z., Wickenhauser, C., Beyer, M., Debey-Pascher, S., et al. (2008). Infection of myeloid dendritic cells with Listeria monocytogenes leads to the suppression of T cell function by multiple inhibitory mechanisms. J. Immunol. 181, 4976-4988. doi: 10.4049/jimmunol.181.7.4976
90. Porcheray, F., Viaud, S., Rimaniol, A.-C., Léone, C., Samah, B., Dereuddre-Bosquet, N., et al. (2005). Macrophage activation switching: an asset for the resolution of inflammation. Clin. Exp. Immunol. 142, 481-489. doi: 10.1111/j.1365-2249.2005.02934.x
91. Pull, S. L., Doherty, J. M., Mills, J. C., Gordon, J. I., Stappenbeck, T. S., and Olson, E. N. (2005). Activated macrophages are an adaptive element of the colonic epithelial progenitor niche necessary for regenerative responses to injury. Proc. Natl. Acad. Sci. U.S.A. 102, 99-104. doi: 10.1073/pnas.0405979102
92. Qian, B.-Z., and Pollard, J. W. (2010). Macrophage diversity enhances tumor progression and metastasis. Cell 141, 39-51. doi: 10.1016/j.cell.2010.03.014
93. Quarto, R., Mastrogiacomo, M., Cancedda, R., Kutepov, S. M., Mukhachev, V., Lavroukov, A., et al. (2001). Repair of large bone defects with the use of autologous bone marrow stromal cells. N. Engl. J. Med. 344, 385-386. doi: 10.1056/NEJM200102013440516
94. Romieu-Mourez, R., François, M., Boivin, M.-N., Stagg, J., and Galipeau, J. (2007). Regulation of MHC class II expression and antigen processing in murine and human mesenchymal stromal cells by IFN-gamma, TGF-beta, and cell density. J. Immunol. 179, 1549-1558. doi: 10.4049/jimmunol.179.3.1549
95. Rutgeerts, P., Sandborn, W. J., Feagan, B. G., Reinisch, W., Olson, A., Johanns, J., et al. (2005). Infliximab for induction and maintenance therapy for ulcerative colitis. N. Engl. J. Med. 353, 2462-2476. doi: 10.1056/NEJMoa050516
96. Sacchetti, B., Funari, A., Remoli, C., Giannicola, G., Kogler, G., Liedtke, S., et al. (2016). No identical 'mesenchymal stem cells' at different times and sites: human committed progenitors of distinct origin and differentiation potential are incorporated as adventitial cells in microvessels. Stem Cell Rep. 6, 897-913. doi: 10.1016/j.stemcr.2016.05.011
97. Sala, E., Genua, M., Petti, L., Anselmo, A., Arena, V., Cibella, J., et al. (2015). Mesenchymal stem cells reduce colitis in mice via release of TSG6, independently of their localization to the intestine. Gastroenterology 149, 163.e20-176.e20. doi: 10.1053/j.gastro.2015.03.013
98. Selleri, S., Bifsha, P., Civini, S., Pacelli, C., Dieng, M. M., Lemieux, W., et al. (2016). Human mesenchymal stromal cell-secreted lactate induces M2-macrophage differentiation by metabolic reprogramming. Oncotarget 7, 30193-30210. doi: 10.18632/oncotarget.8623
99. Serena, C., Keiran, N., Madeira, A., Maymó-Masip, E., Ejarque, M., Terrón-Puig, M., et al. (2017). Crohn's disease disturbs the immune properties of human adipose-derived stem cells related to inflammasome activation. Stem Cell Rep. 9, 1109-1123. doi: 10.1016/j.stemcr.2017.07.014
100. Siegel, C. A. (2011). Review article: explaining risks of inflammatory bowel disease therapy to patients. Aliment. Pharmacol. Ther. 33, 23-32. doi: 10.1111/j.1365-2036.2010.04489.x
101. Smith, P., Mangan, N. E., Walsh, C. M., Fallon, R. E., McKenzie, A. N. J., van Rooijen, N., et al. (2007). Infection with a helminth parasite prevents experimental colitis via a macrophage-mediated mechanism. J. Immunol. 178, 4557-4566. doi: 10.4049/jimmunol.178.7.4557
102. Smith, T. D., Tse, M. J., Read, E. L., and Liu, W. F. (2016). Regulation of macrophage polarization and plasticity by complex activation signals. Integr. Biol. 8, 946-955. doi: 10.1039/C6IB00105J
103. Smythies, L. E., Sellers, M., Clements, R. H., Mosteller-Barnum, M., Meng, G., Benjamin, W. H., et al. (2005). Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J. Clin. Invest. 115, 66-75. doi: 10.1172/JCI200519229
104. Song, J., Kang, H. J., Hong, J. S., Kim, C. J., Shim, J.-Y., Lee, C. W., et al. (2017). Umbilical cord-derived mesenchymal stem cell extracts reduce colitis in mice by re-polarizing intestinal macrophages. Sci. Rep. 7:9412. doi: 10.1038/s41598-017-09827-5
105. Song, W.-J., Li, Q., Ryu, M.-O., Ahn, J.-O., Bhang, D. H., Jung, Y. C., et al. (2017). TSG-6 secreted by human adipose tissue-derived mesenchymal stem cells ameliorates DSS-induced colitis by inducing M2 macrophage polarization in mice. Sci. Rep. 7:5187. doi: 10.1038/s41598-017-04766-7
106. Song, Y., Dou, H., Li, X., Zhao, X., Li, Y., Liu, D., et al. (2017). Exosomal miR-146a contributes to the enhanced therapeutic efficacy of interleukin-1β-primed mesenchymal stem cells against sepsis. Stem Cells 35, 1208-1221. doi: 10.1002/stem.2564
107. Stein, M., Keshav, S., Harris, N., and Gordon, S. (1992). Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J. Exp. Med. 176, 287-292. doi: 10.1084/jem.176.1.287
108. Takeyama, H., Mizushima, T., Uemura, M., Haraguchi, N., Nishimura, J., Hata, T., et al. (2017). Adipose-derived stem cells ameliorate experimental murine colitis via TSP-1-dependent activation of latent TGF-β. Dig. Dis. Sci. 62, 1963-1974. doi: 10.1007/s10620-017-4578-y
109. Tarique, A. A., Logan, J., Thomas, E., Holt, P. G., Sly, P. D., and Fantino, E. (2015). Phenotypic, functional, and plasticity features of classical and alternatively activated human macrophages. Am. J. Respir. Cell Mol. Biol. 53, 676-688. doi: 10.1165/rcmb.2015-0012OC
110. Thomas, A. C., and Mattila, J. T. (2014). 'Of mice and men': arginine metabolism in macrophages. Front. Immunol. 5:479. doi: 10.3389/fimmu.2014.00479
111. Tokuyama, H., Ueha, S., Kurachi, M., Matsushima, K., Moriyasu, F., Blumberg, R. S., et al. (2005). The simultaneous blockade of chemokine receptors CCR2, CCR5 and CXCR3 by a non-peptide chemokine receptor antagonist protects mice from dextran sodium sulfate-mediated colitis. Int. Immunol. 17, 1023-1034. doi: 10.1093/intimm/dxh284
112. Ueda, Y., Kayama, H., Jeon, S. G., Kusu, T., Isaka, Y., Rakugi, H., et al. (2010). Commensal microbiota induce LPS hyporesponsiveness in colonic macrophages via the production of IL-10. Int. Immunol. 22, 953-962. doi: 10.1093/intimm/dxq449
113. Ullman, T. A., and Itzkowitz, S. H. (2011). Intestinal inflammation and cancer. Gastroenterology 140, 1807.e1-1816.e1. doi: 10.1053/j.gastro.2011.01.057
114. Van Den Bossche, J., Baardman, J., Otto, N. A., Hoeksema, M. A., De Vos, A. F., De Winther Correspondence, M. P. J., et al. (2016). Mitochondrial dysfunction prevents repolarization of inflammatory macrophages. Cell Rep. 17, 684-696. doi: 10.1016/j.celrep.2016.09.008
115. Vasandan, A. B., Jahnavi, S., Shashank, C., Prasad, P., Kumar, A., and Prasanna, S. J. (2016). Human mesenchymal stem cells program macrophage plasticity by altering their metabolic status via a PGE 2-dependent mechanism. Sci. Rep. 6:38308. doi: 10.1038/srep38308
116. von Bahr, L., Sundberg, B., Lönnies, L., Sander, B., Karbach, H., Hägglund, H., et al. (2012). Long-term complications, immunologic effects, and role of passage for outcome in mesenchymal stromal cell therapy. Biol. Blood Marrow Transplant. 18, 557-564. doi: 10.1016/j.bbmt.2011.07.023
117. Vos, A. C., Wildenberg, M. E., Arijs, I., Duijvestein, M., Verhaar, A. P., de Hertogh, G., et al. (2012). Regulatory macrophages induced by infliximab are involved in healing in vivo and in vitro. Inflamm. Bowel Dis. 18, 401-408. doi: 10.1002/ibd.21818
118. Vos, A. C., Wildenberg, M. E., Duijvestein, M., Verhaar, A. P., van den Brink, G. R., and Hommes, D. W. (2011). Anti-tumor necrosis factor-a antibodies induce regulatory macrophages in an Fc region-dependent manner. Gastroenterology 140, 221.e3-230.e3. doi: 10.1053/j.gastro.2010.10.008
119. Wang, C., Chen, J., Sun, L., and Liu, Y. (2014). TGF-β signaling-dependent alleviation of dextran sulfate sodium-induced colitis by mesenchymal stem cell transplantation. Mol. Biol. Rep. 41, 4977-4983. doi: 10.1007/s11033-014-3364-6
120. Wei, H., Liu, X., Ouyang, C., Zhang, J., Chen, S., Lu, F., et al. (2017). Complications following stem cell therapy in inflammatory bowel disease. Curr. Stem Cell Res. Ther. 12, 471-475. doi: 10.2174/1574888X12666170315105556
121. Wei, H.-J., Zeng, R., Lu, J.-H., Lai, W.-F. T., Chen, W.-H., Liu, H.-Y., et al. (2015). Adipose-derived stem cells promote tumor initiation and accelerate tumor growth by interleukin-6 production. Oncotarget 6, 7713-7726. doi: 10.18632/oncotarget.3481
122. Wynn, T. A., Chawla, A., and Pollard, J. W. (2013). Macrophage biology in development, homeostasis and disease. Nature 496, 445-455. doi: 10.1038/nature12034
123. Xavier, R. J., and Podolsky, D. K. (2007). Unravelling the pathogenesis of inflammatory bowel disease. Nature 448, 427-434. doi: 10.1038/nature06005
124. Xue, J., Schmidt, S. V., Sander, J., Draffehn, A., Krebs, W., Quester, I., et al. (2014). Transcriptome-based network analysis reveals a spectrum model of human macrophage activation. Immunity 40, 274-288. doi: 10.1016/j.immuni.2014.01.006
125. Zhang, J., Lv, S., Liu, X., Song, B., and Shi, L. (2017). Umbilical cord mesenchymal stem cell treatment for Crohn's disease: a randomized controlled clinical trial. Gut Liver. 12, 73-78. doi: 10.5009/gnl17035
126. Zhang, Q.-Z., Su, W.-R., Shi, S.-H., Wilder-Smith, P., Xiang, A. P., Wong, A., et al. (2010). Human gingiva-derived mesenchymal stem cells elicit polarization of m2 macrophages and enhance cutaneous wound healing. Stem Cells 28, 1856-1868. doi: 10.1002/stem.503
127. Zigmond, E., Bernshtein, B., Friedlander, G., Walker, C. R., Yona, S., Kim, K.-W., et al. (2014). Macrophage-restricted interleukin-10 receptor deficiency, but not IL-10 deficiency, causes severe spontaneous colitis. Immunity 40, 720-733. doi: 10.1016/j.immuni.2014.03.012